Two oral presentations will highlight Phase 2 results from the ASTX030-01 trial of oral azacitidine and cedazuridine in patients with myelodysplastic syndromes, chronic myelomonocytic leukemia or acute myeloid leukemia and Phase 2 results from ASTX727-03 trial of low-dose oral decitabine…
New recommendations on technology, obesity medications, and nutrition
MECHANICSBURG, Pa., Dec. 8, 2025 /PRNewswire/ — Residential Home Health and Hospice, a division of Graham Healthcare Group, is proud to announce that it has been named as one of the Best Places to Work in PA by the Central…
Sign-ups open December 8; Challenge runs January 12 through February 8
Workers Secure Teamsters Representation after Seven Weeks on Picket Line
SANDY HOOK, Conn., Dec. 5, 2025 /PRNewswire/ — SMT Corp, a global leader in the sourcing and advanced testing of electrical, electronic, and electromechanical (EEE) components, today announced a significant expansion of its accreditation portfolio. The company’s ISO/IEC 17025:2017 and…
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — ALR Technologies SG Ltd (“ALRT” or the “Company”) (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM (“GluCurve”) showing accuracy results comparative to the…
New AI Evaluation Ecosystem SeekrGuard helps organizations identify adverse model behaviors and ensure that the U.S. is at the Forefront of Evaluating National Security Risks in Frontier Models
(BPT) – For 36-year-old Austin, Texas, resident David R., kidney disease was something he never expected. After months of feeling sluggish, nauseous and experiencing cramping in his hands and feet, he made an appointment to see his doctor to discuss…
The Iconic Island Destination Debuts with Contemporary Architecture, Elevated Culinary Experiences, and the Launch of The Ritz-Carlton Spa, Key Biscayne